-
Views
-
Cite
Cite
Oritavancin for the Treatment of Serious Gram-Positive Infections, Clinical Infectious Diseases, Volume 54, Issue suppl_3, April 2012, Page NP, https://doi.org/10.1093/cid/cis326
- Share Icon Share
Extract
Guest Editors: Robert C. Moellering Jr, MD
Mary Jane Ferraro, PhD
This supplement was sponsored by a grant from The Medicines Company.
Issue Section:
Guest Editors and Sponsor
You do not currently have access to this article.